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Introduction
Acute rhabdomyolysis (RM) is a serious event often requiring critical care management.
Precipitating causes include a range of environmental trigger(s) with and without a known genetic predisposition [1] . In many cases no cause is found. Here we report eight patients who on next-generation sequencing (NGS) were found to carry four heterozygous missense CAV3 mutations after extensive earlier investigations had been negative. Our findings expand the CAV3-related phenotypical spectrum, so far comprising limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy, isolated hyperCKemia and familial hypertrophic cardiomyopathy [2] .
Materials and methods:
Eight patients presenting with exercise intolerance, myalgia and/or recurrent RM who remained genetically unresolved despite extensive previous investigations are reported. Six patients (patients 1-5 and 8) were identified from a larger cohort of 225 patients with exercise intolerance, myalgia and/or recurrent RM. DNA from patient 6 (the father of patient 5) was assessed following a genetic diagnosis in his son. Patient 7 was genetically investigated following muscle biopsy analysis. Approval was obtained from the regional ethics committee, and informed consent was obtained from all subjects for genetic studies. Medical notes were reviewed retrospectively and patients were reassessed following the genetic diagnosis, except patients 1,3 and 4 who failed to attend follow up visits, and patient 6, who is deceased. Clinical findings are summarized in Table 1 , including: age of onset, age at assessment, presenting symptom, recurrent RM and its triggers, reported rippling muscle contraction, percussion-induced rapid muscle contractions (PIRCs) assessed during physical exam (by a reflex hammer (percussion of a muscle)), muscle pain, muscle weakness assessed during physical exam, reported exercise intolerance (defined as pain and/or a cramp-like sensation during exercise), fatigue and baseline serum creatine kinase (CK) levels.
Histopathological studies were performed as described in Supplementary Material.
Polyacrylamide gel electrophoresis and western blotting were performed as previously described [3] . Blots were incubated with 43DAG/8D5 (β-dystroglycan, Leica Biosystems, DNA from six patients was sequenced by a NGS Illumina 'Trusight One' enrichment panel; designed to screen for 60 relevant genes, previously associated or putatively linked with RM (for review [1] mutations were confirmation by bi-directional Sanger sequencing. Mutations were described using the single letter nomenclature to describe non-synonymous variants.
Results:
The clinical history from each patient is outlined below and key findings are summarized in Table 1 were reduced by more than 50% compared to controls (Fig 2) . β-dystroglycan, used as a loading control, also had reduced levels in three of the samples (Patients 1,2,4 ). Caveolin-3
was markedly reduced on muscle tissue sections from Patient 7 and absent on WB on the same tissue ( Supplementary Fig 1) .
Discussion
We present eight patients with myalgia (n=7), exercise intolerance (n=7) and recurrent RM (n=2) who were found to carry mutations in CAV3; a few of them had been screened for selected metabolic myopathies before NGS was performed. The use of NGS is rapidly expanding the phenotypic spectrum of many neuromuscular disease genes, as sequencing of disease genes is done in an unbiased approach, influencing future classification of disease phenotypes and inherited disorders. This case series illustrates that a "metabolic phenotype", so far more frequently recognized in association with disorders of muscle metabolism (e.g.:
glycogen storage disorders and disorders of fatty acid metabolism), may also be part of the phenotypic spectrum of proteins without immediately apparent primary metabolic link such as caveolin-3. As opposed to disorders of muscle metabolism, there was no clear provoking trigger for RM episodes in the reported cases. Patient 1 had no clear trigger for several episodes of RM. It is unclear if exercise, infection or the combination of both contributed to the RM episodes in patient 3, who also developed a third episode with no apparent trigger.
CAV3 encodes caveolin-3, a muscle specific plasma membrane protein involved in several processes related to the formation of caveolae, invaginations of the plasma membrane. Autosomal dominant -and, less frequently, recessive -CAV3 mutations have been implicated in hyperCKaemia, rippling muscle disease and LGMD1C [2] . Recurrent RM has been previously described in only one patient with a CAV3 mutation, in whom NGS had not been performed to exclude other genetic causes of RM [5] . Our findings suggest that reported in one patient with CAV3 mutations [5] , and paroxysmal muscle weakness, a novel association.
Primary protein defects and absence of caveolin-3 staining on immunohistochemistry is well documented in patients with caveolinopathies [2] . The key histopathological finding in patient 7 was marked reduction of immunostaining for caveolin-3; in combination with an absent band on WB, supporting the pathogenicity of the novel p.F41S substitution. Almost complete absence of caveolin-3 on immunoblotting of patient 8 (p.F54V) supported pathogenicity. These variants were absent from or expressed at a low frequency (0.0008%) in ExAC, respectively. The three muscle biopsies from patients harbouring the p.V14I and p.T78M substitutions showed only minor non-specific histochemical findings and normal caveolin-3 immunostaining. However, reduced caveolin-3 levels on WB, supported the pathogenicity of these mutations and suggested that WB may be the more sensitive method to detect caveolin-3 deficiency. Reijneveld et al. also identified normal caveolin-3 immunostaining in two patients with hyperCKaemia, one with the p.T78M substitution [6] .
Although these and our own observations indicate sufficient caveolin-3 expression to generate a normal immunostaining pattern, it is currently uncertain if the p.V14I and p.T78M substitutions exert their pathogenic effect through relative reduction or abnormal protein function, or both.
Bioinformatics analysis (Table 2 ) predicts that p.T78M is damaging and it has been described in association with long QT syndrome and sudden death [7, 8] , isolated hyperCKaemia [6] , and rippling muscle disease with proximal myopathy in a patient carrying a D4Z4 FSHD-sized allele [9] . Bioinformatic programs also predicted the p.F41S and p.F54V
substitutions to be pathogenic, while the p.V14I substitution was predicted to be benign by all programs.
The interaction between caveolin-3 and the skeletal muscle ryanodine receptor (RyR1), involved in excitation-contraction coupling (ECC) and also implicated in virally-and exercise induced myalgia and rhabdomyolysis [10, 11] , could be of potential relevance to the phenotype observed in our patients. Both caveolin-3 and RyR1 co-localize at the T-tubule and sarcoplasmic reticulum (SR), and a critical role for caveolin-3 has been suggested in the correct localization of RyR1 to the SR and as a modifier of ECC [12, 13] .
The significance of β-dystroglycan reduction in three WB samples is uncertain, even though β-dystroglycan, is a known interactor of caveolins [14, 15] . Myosin heavy chain was also used as a protein loading control, ensuring that this observation is not due to uneven loading of skeletal muscle protein.
A limitation of this study was the inability to perform co-segregation studies in other family members to strengthen the pathogenicity of the CAV3 variants and to evaluate their penetrance. In addition, future more detailed functional characterization may clarify the precise pathogenic effect of the new CAV3 variants and their role in genetic counselling, and additional genetic modifiers with potential synergistic effects may be identified.
Conclusions
In summary, myalgia, exertion intolerance and recurrent RM are features associated with CAV3 mutations, highlighting the broad and expanding spectrum of caveolinopathies. 
